The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting &#x3b2;(2)-Agonist Over-Reliance in Asthma: An Expert Opinion

Asthma

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study

J Clin Med

Oga T, Gon Y, Takano M, Ito R, Mita C, Mukai I, Noorduyn SG, Requena G, Yarita M

doi: 10.3390/jcm14082566

COPD

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS

Respir Res

Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M

doi: 10.1186/s12931-025-03234-5

RECOMMENDED

Asthma

The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Adv Ther

Kaplan A, Heatley H, Townend J, Skinner D, Carter V, Hubbard R, Lee TT, Koh MS, Price D

doi: 10.1007/s12325-025-03175-x

COMMENTED

AsthmaFurther Publications

Cohort multiple randomized controlled trial in pediatric asthma to assess the long- and short-term effects of eHealth interventions: protocol of the CIRCUS study

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Ther Adv Respir Dis

Ruuls T, Sprengers R, Hengeveld V, Thio B, Tabak M, Zagers D, van der Palen J, van der Kamp M

doi: 10.1177/17534666251323192

RECOMMENDED

Further Publications

Dual αvβ6 and αvβ1 Inhibition Over 12 Weeks Reduces Active Type 1 Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial

★ 2 Recommended by Dr Martin Frey, Faculty Member

Am J Respir Crit Care Med

Montesi SB, Cosgrove GP, Turner SM, Zhou IY, Efthimiou N, Susnjar A, Catana C, Fromson C, Clark A, Decaris M, Barnes CN, Lefebvre ÉA, Caravan P

doi: 10.1164/rccm.202410-1934OC

RECOMMENDED

COPD

Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 1 Recommended by Dr Marcus Hesse, Faculty Member

Respir Med

Shanmugavel Geetha H, Teo YX, Ravichandran S, Perkitt NR, Gogtay M, Lal A, Abraham GM, Trivedi N

doi: 10.1016/j.rmed.2024.107819

Asthma

Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry

Respir Med

Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen IK, Soyyigit S, Yakut T, Havlucu Y, Aydin O, Buhari GK, Sozener ZC, Bulut I, Beyaz S, Orcen C, Ozdemir SK, Keren M, Damadoglu E, Kalpaklioglu AF, Baccioglu A, Yalim SA, Yilmaz I, Kalkan IK, Uysal MA, Ozgun Niksarlioglu EY, Kalyoncu AF, Karakaya G, Erbay M, Nayci S, Tepetam FM, Gelincik A, Dirol H, Goksel O, Karaoglanoglu S, Erkekol FO, Isik SR, Yildiz F, Yavuz Y, Karadogan D, Bozkurt N, Seker U, Basyigit I, Baris SA, Ucar EY, Erdogan T, Polatli M, Ediger D, Gunaydin FE, Turk M, Pur L, Katran ZY, Sekibag Y, Aykac EF, Mungan D, Gul O, Cengiz A, Akkurt B, Ozden S, Demir S, Unal D, Aslan AF, Gumusburun R, Bogatekin G, Akten HS, Inan S, Erdinc M, Ogus AC, Kavas M, Yulug DP, Cakmak ME, Kaya SB, Alpagat G, Ozgur ES, Uzun O, Gulen ST, Pekbak G, Kizilirmak D, Donmez H, Arslan B, Cetin GP, Kara BY, Dursun AB, Karakis GP, Kendirlinan R, Ozturk AB, Simsek GO, Abadoglu O, Cerci P, Yucel T, Yorulmaz I, Tezcaner ZC, Tatar EC, Suslu AE, Ozer S, Dursun E, Yorgancioglu A, Çelik GE

doi: 10.1016/j.rmed.2024.107883

COMMENTED

Asthma

Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial

★ 3 Recommended and commented by Dr Martin Frey, Faculty Member

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Lancet Respir Med

Castro M, Papi A, Porsbjerg C, Lugogo NL, Brightling CE, González-Barcala FJ, Bourdin A, Ostrovskyy M, Staevska M, Chou PC, Duca L, Pereira AM, Fogarty C, Nadama R, Zhang M, Rodrigues A, Soler X, Sacks HJ, Deniz Y, Rowe PJ, de Prado Gómez L, Jacob-Nara JA

doi: 10.1016/S2213-2600(24)00362-X

COMMENTED

Asthma

XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma

★ 3 Recommended and commented by Dr Marcus Hesse, Faculty Member

Chest

Pelaia G, Jackson DJ, Nair P, Emmanuel B, Tran TN, Menzies-Gow A, Watt M, Kayaniyil S, Boarino S, Nuevo J, Pardal M, Shavit A, Shih VH, Cohen D, Loureiro C, Padilla-Galo A

doi: 10.1016/j.chest.2025.04.011

Pneumology

The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β(2)-Agonist Over-Reliance in Asthma: An Expert Opinion

Related content

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS

The Real-World Impact of Glucagon-Like Peptide 1 Receptor Agonists on Asthma Control in People with High-Risk Asthma and Obesity

Cohort multiple randomized controlled trial in pediatric asthma to assess the long- and short-term effects of eHealth interventions: protocol of the CIRCUS study

Dual αvβ6 and αvβ1 Inhibition Over 12 Weeks Reduces Active Type 1 Collagen Deposition in Individuals with Idiopathic Pulmonary Fibrosis: A Phase 2, Double-Blind, Placebo-controlled Clinical Trial

Use of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitor is Associated with reduced Emergency Room Visits and Hospitalization in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Diabetes Mellitus

Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry

Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial

XALOC-1: Clinical remission over 2-years with benralizumab in severe eosinophilic asthma